Constant insulin growth factor binding protein-3 - Taiwan Registration 7946f8a83414d898fd1bc588ea3f3e6c
Access comprehensive regulatory information for Constant insulin growth factor binding protein-3 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7946f8a83414d898fd1bc588ea3f3e6c and manufactured by IMMUNOTECH s.r.o.. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Radioimmunoassay quantification was used to detect IGF BP-3 pancreatic hormones in serum.
A Clinical chemistry and clinical toxicology
A.1370 Human Growth Hormone Testing System
Consent must be attached to the import (with the consent of the Atomic Energy Commission must be obtained for each import); input
Dates and Status
Feb 03, 2006
Feb 03, 2016
Apr 25, 2018
Cancellation Information
Logged out
่ช่ก้ตๅ ฅ